Invitation: 14 May 2020 – The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19 health technologies

On 14 May 2020, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos will convene a briefing entitled: “The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19 health technologies.” This side event in advance of the virtual 73rd session of the World Health Assembly will take place on 14 May 2020 from 15h00 CET to 16h30 CET.

Details on how to participate will be sent to registered attendees. Registration can be done by filling out this form.

Moderator: Ellen ‘t Hoen, LLM, PhD, Director, Medicines Law & Policy

Speakers:

  • Dr Mariângela Simão, Assistant Director-General Access to Medicines and Health Products, World Health Organization
  • Dr. Daniel Salas Peraza, Minister of Health, Costa Rica
  • Roman Macaya, MBA, PhD, Executive President of the Board of Directors of the Costa Rican Social Security Fund
  • Dr Philippe Duneton, Executive Director a.i., Unitaid
  • James Love, Director, Knowledge Ecology International (KEI)
  • Dr Marie-Paule Kieny, Director of research, Inserm, France; Chair of the Board, Drugs for Neglected Diseases Initiative (DNDi) and
    Medicines Patent Pool Foundation (MPPF), Geneva, Switzerland
  • Dr. Carlos María Correa, Executive Director, South Centre
  • Paul Fehlner, Paul Fehlner, PhD, President & CEO, reVision Therapeutics, Inc
  • Charles Gore, Executive Director, Medicines Patent Pool
  • Bernard Pecoul, Executive Director, Drugs for Neglected Diseases initiative (DNDi)

Look forward to seeing you there!

Avatar photo
+ posts

Kaitlin Mara, MSc, has been writing about international intellectual property and innovation policy for a over 15 years.

Newsletter

Never miss a post! Sign up for ML&P's newsletter.

Recent Articles

“Mutually agreed terms and conditions,” says it all.

On 4 March, Politico reported that the Polish presidency of the Council of the European Union (EU) is expressing doubt that the Pandemic Agreement...

“This week, the medicines were not there”: What is at stake in the pandemic agreement

Earlier this week I listened to a testimony from a community worker at a maternity ward where HIV-positive women gave birth. 17 babies were...

A better way to solve a crisis: A new mechanism for incentivising R&D on new antimicrobials

Antimicrobial resistance is the ‘silent’ pandemic: Globally, it costs 5 million lives a year, and is set to rise to more than 8 million...

The world needs a signal that multilateralism works: ML&P opening statement to the INB13, 17 February 2025

Thank you for the opportunity to make a brief statement. The negotiations for the Pandemic Agreement enter the final phase. We hope and wish for...

Trump Administration poses an unprecedented threat to life-saving health programmes 

On his first day in office, US President Trump issued several executive orders, one of which concerns US foreign aid. This order included a...

Related Articles